Notícias e Atividades da Deciphera Pharmaceuticals
Presença
Sede: Estados Unidos
ONO Pharmaceutical é uma das ...
ONO Pharmaceutical é uma empresa listada sob o símbolo 4528 (JP).
ONO Pharmaceutical tem presença direta em 2 países.
Executivos
Veja o organograma con seus 27 executivos principais
Biografias mais buscadas da Deciphera Pharmaceuticals
- Ryota Udagawa, Chief Executive Officer and President
- Toichi Takino, Director
- Masayuki Tanigawa, Director
Recentes movimentos de executivos em Deciphera Pharmaceuticals
- Cynthia Fairbairn, Director, Clinical Operations, deixou a Companhia (Notícia publicada em 3 de abril de 2026).
- Margarida Duarte, Executive Vice President and Global Chief Commercial Officer, deixou a Companhia (Notícia publicada em 3 de abril de 2026).
- Lisa Amaya Price, Senior Vice President and Chief Human Resources Officer, deixou a Companhia (Notícia publicada em 13 de janeiro de 2026).
Recentes movimentos de executivos em ONO Pharmaceutical
- Toshihiro Tsujinaka antes Executive Director, Corporate Strategy & Planning, agora é Representative Director, Senior Executive Officer, Chief Officer of CMC & Production (Notícia publicada em 3 de março de 2026).
- Harumi Nakano antes Senior Director, Corporate Strategy & Planning, Business Management, agora é Corporate Officer, Senior Director, Finance & Accounting Department (Notícia publicada em 3 de março de 2026).
- Masaki Itoh antes Corporate Officer, Division Director, Corporate Strategy & Planning, Business Management Division, Business Management Department and President, Ono Digital health Investment, agora é Corporate Executive Officer, Chief Officer of Finance & Accounting (Notícia publicada em 3 de março de 2026).
Clique aqui para ver outras movimentos em ONO Pharmaceutical
Criar um alerta
para seguir os movimentos de executivos da Deciphera Pharmaceuticals.
Farmacêutica
ONO Pharmaceutical possui 1.920 concorrentes concorrentes Sanofi (França), Moderna (Estados Unidos) e Eli Lilly (Estados Unidos).
Popular M&A news in Farmacêutica
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- Agenus acaba de anunciar uma arrecadação de fundos de 340 milhões de dólares. (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Deciphera Pharmaceuticals na LinkedIn, X (Twitter) e YouTube
